These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 924245)

  • 41. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Feb; 1(7902):343. PubMed ID: 46493
    [No Abstract]   [Full Text] [Related]  

  • 44. Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Mar; 1(7909):744. PubMed ID: 47503
    [No Abstract]   [Full Text] [Related]  

  • 45. [Multicenter clinical study on therapy with digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(11):1737-72. PubMed ID: 543885
    [No Abstract]   [Full Text] [Related]  

  • 46. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Sep; 16(3):444-8. PubMed ID: 4412196
    [No Abstract]   [Full Text] [Related]  

  • 47. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses.
    Lloyd BL; Greenblatt DJ; Allen MD; Harmatz JS; Smith TW
    Am J Cardiol; 1978 Jul; 42(1):129-36. PubMed ID: 677028
    [No Abstract]   [Full Text] [Related]  

  • 50. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Shimamoto T; Yashiki T; Ogawa Y; Uda Y; Nishida Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):576-81. PubMed ID: 6818163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological availability of digoxin.
    Shaw TR
    Br Heart J; 1973 May; 35(5):554-5. PubMed ID: 4577277
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
    Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation: evaluation for sublingual and oral administrations in humans].
    Seo H; Uekama K
    Yakugaku Zasshi; 1989 Oct; 109(10):778-82. PubMed ID: 2621567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability and digoxin.
    N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
    [No Abstract]   [Full Text] [Related]  

  • 57. Correlation of digoxin-tablet dissolution-rate with biological availability.
    Lindenbaum J; Butler VP; Murphy JE; Cresswell RM
    Lancet; 1973 Jun; 1(7814):1215-7. PubMed ID: 4122564
    [No Abstract]   [Full Text] [Related]  

  • 58. Digoxin bioavailability: evaluation of a generic tablet and proposed FDA guidelines.
    Kramer WG; Kolibash AJ; Bathala MS; Visconti JA; Lewis RP; Reuning RH
    J Pharm Sci; 1977 Dec; 66(12):1720-2. PubMed ID: 925936
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
    Asmussen B; Heinz N
    Arzneimittelforschung; 1980; 30(12):2168-72. PubMed ID: 7194080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability of digoxin.
    Bertler A; Redfors A; Medin S; Nyberg L
    Lancet; 1972 Sep; 2(7779):708. PubMed ID: 4115839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.